Perrigo Company plc (NYSE:PRGO) Holdings Raised by Victory Capital Management Inc.

Victory Capital Management Inc. increased its stake in Perrigo Company plc (NYSE:PRGO) by 3.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,107,135 shares of the company’s stock after purchasing an additional 37,758 shares during the quarter. Victory Capital Management Inc. owned approximately 0.82% of Perrigo worth $35,628,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Hexagon Capital Partners LLC purchased a new position in shares of Perrigo in the fourth quarter worth approximately $37,000. Retirement Systems of Alabama grew its position in Perrigo by 0.4% during the 4th quarter. Retirement Systems of Alabama now owns 169,715 shares of the company’s stock worth $5,461,000 after purchasing an additional 657 shares in the last quarter. Bahl & Gaynor Inc. raised its stake in Perrigo by 1.4% during the 4th quarter. Bahl & Gaynor Inc. now owns 839,558 shares of the company’s stock valued at $27,017,000 after purchasing an additional 11,913 shares during the period. Semanteon Capital Management LP purchased a new stake in shares of Perrigo in the fourth quarter valued at $835,000. Finally, State of New Jersey Common Pension Fund D boosted its position in shares of Perrigo by 18.1% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 82,157 shares of the company’s stock worth $2,644,000 after buying an additional 12,603 shares during the period. Institutional investors and hedge funds own 95.91% of the company’s stock.

Insider Buying and Selling

In related news, EVP Alison Ives purchased 2,490 shares of the stock in a transaction on Tuesday, March 5th. The shares were bought at an average price of $27.26 per share, for a total transaction of $67,877.40. Following the completion of the acquisition, the executive vice president now directly owns 16,122 shares in the company, valued at approximately $439,485.72. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Perrigo news, CEO Patrick Lockwood-Taylor bought 9,500 shares of the stock in a transaction on Thursday, February 29th. The shares were purchased at an average price of $26.54 per share, with a total value of $252,130.00. Following the acquisition, the chief executive officer now directly owns 20,500 shares of the company’s stock, valued at approximately $544,070. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Alison Ives purchased 2,490 shares of the company’s stock in a transaction on Tuesday, March 5th. The stock was acquired at an average cost of $27.26 per share, for a total transaction of $67,877.40. Following the completion of the transaction, the executive vice president now owns 16,122 shares in the company, valued at $439,485.72. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 17,990 shares of company stock worth $475,227. 0.40% of the stock is currently owned by insiders.

Analysts Set New Price Targets

PRGO has been the topic of several recent analyst reports. Canaccord Genuity Group reissued a “buy” rating and set a $42.00 price target on shares of Perrigo in a research report on Friday, April 12th. JPMorgan Chase & Co. decreased their price target on shares of Perrigo from $48.00 to $41.00 and set an “overweight” rating for the company in a report on Wednesday, February 28th. StockNews.com raised shares of Perrigo from a “hold” rating to a “buy” rating in a research report on Wednesday, April 3rd. Finally, Piper Sandler increased their target price on shares of Perrigo from $35.00 to $39.00 and gave the stock an “overweight” rating in a research report on Monday, April 8th.

Perrigo Trading Up 2.0 %

NYSE:PRGO opened at $33.43 on Tuesday. The stock’s 50 day moving average price is $30.62 and its 200 day moving average price is $30.93. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.79. Perrigo Company plc has a 52 week low of $25.77 and a 52 week high of $40.28.

Perrigo (NYSE:PRGO) last announced its quarterly earnings results on Tuesday, February 27th. The company reported $0.86 EPS for the quarter, topping the consensus estimate of $0.83 by $0.03. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.17 billion. Perrigo had a negative net margin of 0.27% and a positive return on equity of 7.34%. Perrigo’s quarterly revenue was up .1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.75 EPS. On average, analysts forecast that Perrigo Company plc will post 2.55 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Friday, May 31st will be issued a dividend of $0.276 per share. This represents a $1.10 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date of this dividend is Friday, May 31st. Perrigo’s dividend payout ratio is -1,100.00%.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.